Your browser doesn't support javascript.
loading
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Feenstra, Helena M A; Diederen, Roselie M H; Lamme, Martine J C M; Tsonaka, Roula; Fauser, Sascha; Yzer, Suzanne; van Rijssen, Thomas; Gkika, Theodora; Downes, Susan M; Schlingemann, Reinier O; Hoyng, Carel B; van Dijk, Elon H C; Boon, Camiel J F.
Afiliação
  • Feenstra HMA; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Diederen RMH; Department of Ophthalmology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Lamme MJCM; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Tsonaka R; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
  • Fauser S; Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
  • Yzer S; F. Hoffmann-La Roche, Basel, Switzerland.
  • van Rijssen T; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Gkika T; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Downes SM; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Schlingemann RO; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Hoyng CB; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom; and.
  • van Dijk EHC; Department of Ophthalmology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Boon CJF; Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland.
Retina ; 43(3): 379-388, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36727801

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Porfirinas / Coriorretinopatia Serosa Central Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Porfirinas / Coriorretinopatia Serosa Central Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article